IXICO strikes neuroimaging deal with Medidata to expand clinical trial platform

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and biomarker analytics company, has announced a technology collaboration with Medidata, a Dassault Systèmes brand and leading provider of clinical trial software to the life sciences industry. The partnership will integrate IXICO's IXI Platform with the Medidata Platform, creating a unified neuroimaging data and analysis system for biopharma companies running clinical trials in neurological disorders.